Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM PAR
-
Total 13F shares
-
37,779,369
-
Share change
-
-29,659,274
-
Total reported value
-
$9,948,000
-
Put/Call ratio
-
45%
-
Price per share
-
$0.26
-
Number of holders
-
33
-
Value change
-
-$11,764,858
-
Number of buys
-
10
-
Number of sells
-
21
Institutional Holders of SUNESIS PHARMACEUTICALS INC - COM PAR (SNSS) as of Q2 2020
As of 30 Jun 2020,
SUNESIS PHARMACEUTICALS INC - COM PAR (SNSS) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,779,369 shares.
The largest 10 holders included
Aisling Capital Management LP, Nantahala Capital Management, LLC, VANGUARD GROUP INC, CITADEL ADVISORS LLC, BVF INC/IL, BlackRock Inc., NEA Management Company, LLC, Palo Alto Investors LP, GEODE CAPITAL MANAGEMENT, LLC, and BAKER BROS. ADVISORS LP.
This page lists
33
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.